H. (Helicobacter) Pylori Infection - 2024 Pipeline Insights Report Featuring Emerging Drugs Rifasutenizole (TNP-2198) by TenNor Therapeutics (Suzhou) Limited, and SVT1C4610 by Servatus Biopharmaceuticals
27 août 2024 04h15 HE
|
Research and Markets
Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Helicobacter Pylori Infection - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...